Global Strategies for Digital Health Reimbursement
September 18, 2024
10:00 AM – 11:00 AM ET
Join AdvaMed and Avania for this timely webinar on the overall direction for remote technologies, artificial intelligence, and physiologic monitoring systems.
Global Strategies for Digital Health Reimbursement
September 18, 2024
10:00 AM – 11:00 AM ET
Global Strategies for Digital Health Reimbursement
September 18, 2024
10:00 AM – 11:00 AM ET
This in-depth webinar will explore the different classes of digital technology solutions and how they are addressed by coverage, coding, and payment systems in the U.S., France, Germany, the U.K., and Japan. Stephen Hull, a veteran reimbursement consultant, will examine key case studies and discuss the overall direction for remote technologies, artificial intelligence, and physiologic monitoring systems. Key takeaways are:
- U.S. Coding, Coverage, and Payment for Digital Technologies
- France’s Framework for Telehealth and Digital Technologies
- Germany’s Approach to Digital Health
- The U.K.s Localized Approach to Reimbursement
- Japan’s MHLW Framework for Digital Technologies
Join us virtually on September 18th at 10:00 AM ET to explore the overall direction for remote technologies, artificial intelligence, and physiologic monitoring systems.
Meet The Speaker
Stephen Hull is a veteran consultant in market access, having served MedTech companies across all therapeutic areas for over two decades. He is formerly a chair of the ISPOR medical device strategic interest group, and founder of Hull Associates, which was acquired by Avania in 2023.
Mr. Hull served as Sr. Vice President at AdvaMed, in the US Health Policy and International departments, and also was previously a principal at Covance Health Economics and Outcomes Services. He has an advanced degree from Johns Hopkins Bloomberg School of Public Health and an undergraduate degree from Colgate University.
Hear From Us
Sign up to receive emails highlighting our upcoming events, early registration savings, and engagement opportunities for the medical technology community.